Updated Jul 16, 2026
Klein Peter S has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Peter S. Klein is listed as a Director of Denali Therapeutics Inc. in the most recent SEC filing (as of 2026-06-05). The filing provides limited biographical detail beyond confirming the board role; no additional positions, educational background, or career history are disclosed in the provided context. There is no clear public record in this context of other roles or notable achievements. A broader public data search would be needed to verify a more complete biography or confirm overlap with other individuals sharing the same name.
| Role | Director |
|---|---|
| Notability | 55/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | DNLI | Denali Therapeutics Inc. | A — Grant or award | 6.4K | $0.00 |
Peter S. Klein is listed as a Director of Denali Therapeutics Inc. in the most recent SEC filing (as of 2026-06-05). The filing provides limited biographical detail beyond confirming the board role; no additional positions, educational background, or career history are disclosed in the provided context. There is no clear public record in this context of other roles or notable a…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Klein Peter S profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.